BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced ...

BioLife Solutions is headquartered in Bothell, WA. BioLife Solutions manufactures and markets bioproduction tools and services for the cell and gene therapy (CGT) industry. The stock currently ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on BLFS: Biolife Solutions NewsMORE ...

In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on BioLife Solutions (BLFS – Research Report), with a price ...

Cerity Partners LLC grew its stake in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 6.6% in the 3rd quarter, according to the company in its most recent filing with the Securities ...

BioLife Solutions (NASDAQ:BLFS – Get Free Report) had its price objective hoisted by analysts at Northland Securities from $28.00 to $31.00 in a research note issued to investors on Wednesday,Benzinga ...

BOTHELL, Wash., Dec. 16, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

On Thursday, Benchmark maintained its Buy rating on shares of BioLife Solutions (NASDAQ:BLFS) with a steady price target of $30.00. The stock, currently trading at $24.98, has demonstrated strong ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

Cell Processing revenue increased 7% sequentially to $20.3 million Unaudited revenue for FY2024 from Cell Processing of $73.5 million, exceeded the ...